• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

刚性体配体识别驱动细胞毒性 T 淋巴细胞抗原 4(CTLA-4)受体触发。

Rigid-body ligand recognition drives cytotoxic T-lymphocyte antigen 4 (CTLA-4) receptor triggering.

机构信息

Nuffield Department of Clinical Medicine and MRC Human Immunology Unit, The University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DU, United Kingdom.

出版信息

J Biol Chem. 2011 Feb 25;286(8):6685-96. doi: 10.1074/jbc.M110.182394. Epub 2010 Dec 14.

DOI:10.1074/jbc.M110.182394
PMID:21156796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3057841/
Abstract

The inhibitory T-cell surface-expressed receptor, cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), which belongs to the class of cell surface proteins phosphorylated by extrinsic tyrosine kinases that also includes antigen receptors, binds the related ligands, B7-1 and B7-2, expressed on antigen-presenting cells. Conformational changes are commonly invoked to explain ligand-induced "triggering" of this class of receptors. Crystal structures of ligand-bound CTLA-4 have been reported, but not the apo form, precluding analysis of the structural changes accompanying ligand binding. The 1.8-Å resolution structure of an apo human CTLA-4 homodimer emphasizes the shared evolutionary history of the CTLA-4/CD28 subgroup of the immunoglobulin superfamily and the antigen receptors. The ligand-bound and unbound forms of both CTLA-4 and B7-1 are remarkably similar, in marked contrast to B7-2, whose binding to CTLA-4 has elements of induced fit. Isothermal titration calorimetry reveals that ligand binding by CTLA-4 is enthalpically driven and accompanied by unfavorable entropic changes. The similarity of the thermodynamic parameters determined for the interactions of CTLA-4 with B7-1 and B7-2 suggests that the binding is not highly specific, but the conformational changes observed for B7-2 binding suggest some level of selectivity. The new structure establishes that rigid-body ligand interactions are capable of triggering CTLA-4 phosphorylation by extrinsic kinase(s).

摘要

抑制性 T 细胞表面表达的受体,细胞毒性 T 淋巴细胞相关抗原-4(CTLA-4),属于细胞表面蛋白的一类,这些蛋白通过外在的酪氨酸激酶磷酸化,也包括抗原受体,结合相关配体,B7-1 和 B7-2,表达在抗原呈递细胞上。构象变化通常被用来解释这类受体的配体诱导“触发”。已报道了配体结合的 CTLA-4 的晶体结构,但不是无配体的形式,排除了伴随配体结合的结构变化的分析。1.8Å 分辨率的人 CTLA-4 同源二聚体的无配体形式结构强调了 CTLA-4/CD28 免疫球蛋白超家族亚群和抗原受体的共同进化历史。配体结合和未结合的 CTLA-4 和 B7-1 形式非常相似,与 B7-2 形成鲜明对比,B7-2 与 CTLA-4 的结合具有诱导契合的元素。等温热滴定法揭示 CTLA-4 的配体结合是焓驱动的,并伴随着不利的熵变化。确定 CTLA-4 与 B7-1 和 B7-2 相互作用的热力学参数的相似性表明,结合不是高度特异性的,但观察到的 B7-2 结合的构象变化表明存在一定程度的选择性。新结构确立了刚性配体相互作用能够触发 CTLA-4 的外在激酶磷酸化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa0/3057841/b04c167c2989/zbc0111151140007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa0/3057841/38b97badf54b/zbc0111151140001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa0/3057841/90b1b8884d3f/zbc0111151140002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa0/3057841/981410827df1/zbc0111151140003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa0/3057841/9b87ef45b39a/zbc0111151140004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa0/3057841/0e74a0d81ce4/zbc0111151140005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa0/3057841/8a3e1a4ea679/zbc0111151140006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa0/3057841/b04c167c2989/zbc0111151140007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa0/3057841/38b97badf54b/zbc0111151140001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa0/3057841/90b1b8884d3f/zbc0111151140002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa0/3057841/981410827df1/zbc0111151140003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa0/3057841/9b87ef45b39a/zbc0111151140004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa0/3057841/0e74a0d81ce4/zbc0111151140005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa0/3057841/8a3e1a4ea679/zbc0111151140006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dfa0/3057841/b04c167c2989/zbc0111151140007.jpg

相似文献

1
Rigid-body ligand recognition drives cytotoxic T-lymphocyte antigen 4 (CTLA-4) receptor triggering.刚性体配体识别驱动细胞毒性 T 淋巴细胞抗原 4(CTLA-4)受体触发。
J Biol Chem. 2011 Feb 25;286(8):6685-96. doi: 10.1074/jbc.M110.182394. Epub 2010 Dec 14.
2
Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4.CD80 和 CD86 的跨胞吞作用:CTLA-4 细胞外功能的分子基础。
Science. 2011 Apr 29;332(6029):600-3. doi: 10.1126/science.1202947. Epub 2011 Apr 7.
3
The interaction properties of costimulatory molecules revisited.共刺激分子相互作用特性再探讨。
Immunity. 2002 Aug;17(2):201-10. doi: 10.1016/s1074-7613(02)00362-x.
4
Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1.细胞毒性T淋巴细胞相关抗原4(CTLA-4)和CD28中互补决定区1(CDR1)及CDR3类似区域决定了与B7-1的结合。
J Exp Med. 1994 Dec 1;180(6):2049-58. doi: 10.1084/jem.180.6.2049.
5
Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain.B7的突变分析及一种可变剪接产物确定了其在免疫球蛋白C样结构域上的CD28/CTLA4结合位点。
J Exp Med. 1995 Apr 1;181(4):1345-55. doi: 10.1084/jem.181.4.1345.
6
Structural basis for co-stimulation by the human CTLA-4/B7-2 complex.人CTLA-4/B7-2复合物共刺激的结构基础。
Nature. 2001 Mar 29;410(6828):604-8. doi: 10.1038/35069112.
7
Structure of murine CTLA-4 and its role in modulating T cell responsiveness.小鼠CTLA-4的结构及其在调节T细胞反应性中的作用。
Science. 2000 Oct 27;290(5492):816-9. doi: 10.1126/science.290.5492.816.
8
Rescue of thymocytes from glucocorticoid-induced cell death mediated by CD28/CTLA-4 costimulatory interactions with B7-1/B7-2.通过CD28/CTLA-4与B7-1/B7-2共刺激相互作用介导的糖皮质激素诱导的细胞死亡中胸腺细胞的拯救。
J Exp Med. 1996 Nov 1;184(5):1631-8. doi: 10.1084/jem.184.5.1631.
9
Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesis.CD28 对其同源反受体 CD80(B7.1)和 B70(B7.2)的差异识别:定点诱变分析
Mol Immunol. 1996 Feb;33(3):321-34. doi: 10.1016/0161-5890(95)00077-1.
10
Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.人B7-1(CD80)和B7-2(CD86)与CD28和CTLA-4受体结合时亲和力相似,但动力学特性不同。
Immunity. 1994 Dec;1(9):793-801. doi: 10.1016/s1074-7613(94)80021-9.

引用本文的文献

1
Phenotypic and targeted drug discovery in immune therapeutics: challenges, opportunities, and future directions.免疫治疗中的表型和靶向药物发现:挑战、机遇与未来方向。
RSC Adv. 2025 Aug 22;15(36):29937-29951. doi: 10.1039/d5ra03914b. eCollection 2025 Aug 18.
2
Negative Immune Checkpoint Inhibitors.阴性免疫检查点抑制剂
Pharmaceutics. 2025 May 28;17(6):713. doi: 10.3390/pharmaceutics17060713.
3
The Structural Biology of T-Cell Antigen Detection at Close Contacts.紧密接触时T细胞抗原检测的结构生物学

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Domain metastability: a molecular basis for immunoglobulin deposition?域不稳定性:免疫球蛋白沉积的分子基础?
J Mol Biol. 2010 Jun 4;399(2):207-13. doi: 10.1016/j.jmb.2010.04.011. Epub 2010 Apr 13.
3
PHENIX: a comprehensive Python-based system for macromolecular structure solution.PHENIX:一个基于Python的用于大分子结构解析的综合系统。
Immunol Rev. 2025 May;331(1):e70014. doi: 10.1111/imr.70014.
4
Post-translational modifications of immune checkpoints: unlocking new potentials in cancer immunotherapy.免疫检查点的翻译后修饰:开启癌症免疫治疗的新潜力。
Exp Hematol Oncol. 2025 Mar 14;14(1):37. doi: 10.1186/s40164-025-00627-6.
5
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders.自身免疫性疾病的自身免疫机制演变和新的治疗策略。
Signal Transduct Target Ther. 2024 Oct 4;9(1):263. doi: 10.1038/s41392-024-01952-8.
6
Development of an Albumin-Masked mutPD-1Ig as a Tumor Lesion-Selective Immune Checkpoint Inhibitor.开发一种白蛋白掩盖的突变型PD-1Ig作为肿瘤病灶选择性免疫检查点抑制剂。
ACS Omega. 2023 Oct 18;8(43):40911-40920. doi: 10.1021/acsomega.3c06216. eCollection 2023 Oct 31.
7
A lesion-selective albumin-CTLA4Ig as a safe and effective treatment for collagen-induced arthritis.一种病变选择性白蛋白-CTLA4Ig作为胶原诱导性关节炎的安全有效治疗方法。
Inflamm Regen. 2023 Feb 16;43(1):13. doi: 10.1186/s41232-023-00264-8.
8
Rational Strategy for Designing Peptidomimetic Small Molecules Based on Cyclic Peptides Targeting Protein-Protein Interaction between CTLA-4 and B7-1.基于靶向CTLA-4与B7-1之间蛋白质-蛋白质相互作用的环肽设计拟肽小分子的合理策略。
Pharmaceuticals (Basel). 2022 Dec 2;15(12):1506. doi: 10.3390/ph15121506.
9
High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails.利用杂交 ssDNA 修复模板和小分子鸡尾酒在原代细胞中进行高效基因组工程。
Nat Biotechnol. 2023 Apr;41(4):521-531. doi: 10.1038/s41587-022-01418-8. Epub 2022 Aug 25.
10
Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation.CD80 和 CD86 的转胞吞作用差异揭示了 CD86 是 CTLA-4 免疫调节的关键靶点。
Nat Immunol. 2022 Sep;23(9):1365-1378. doi: 10.1038/s41590-022-01289-w. Epub 2022 Aug 23.
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):213-21. doi: 10.1107/S0907444909052925. Epub 2010 Jan 22.
4
Taming tissue-specific T cells: CTLA-4 reins in self-reactive T cells.调控组织特异性 T 细胞:CTLA-4 抑制自身反应性 T 细胞。
Nat Immunol. 2010 Feb;11(2):109-11. doi: 10.1038/ni0210-109.
5
PSI-2: structural genomics to cover protein domain family space.PSI-2:用于覆盖蛋白质结构域家族空间的结构基因组学。
Structure. 2009 Jun 10;17(6):869-81. doi: 10.1016/j.str.2009.03.015.
6
Antigen ligation triggers a conformational change within the constant domain of the alphabeta T cell receptor.抗原连接引发αβ T细胞受体恒定结构域内的构象变化。
Immunity. 2009 Jun 19;30(6):777-88. doi: 10.1016/j.immuni.2009.03.018. Epub 2009 May 21.
7
The clinical utility of inhibiting CD28-mediated costimulation.抑制CD28介导的共刺激的临床应用。
Immunol Rev. 2009 May;229(1):307-21. doi: 10.1111/j.1600-065X.2009.00780.x.
8
An engineered lipocalin specific for CTLA-4 reveals a combining site with structural and conformational features similar to antibodies.一种针对细胞毒性T淋巴细胞相关抗原4(CTLA-4)的工程化脂笼蛋白揭示了一个与抗体具有相似结构和构象特征的结合位点。
Proc Natl Acad Sci U S A. 2009 May 19;106(20):8198-203. doi: 10.1073/pnas.0813399106. Epub 2009 May 5.
9
The CATH classification revisited--architectures reviewed and new ways to characterize structural divergence in superfamilies.重温CATH分类——超家族中结构差异的架构综述及新表征方法
Nucleic Acids Res. 2009 Jan;37(Database issue):D310-4. doi: 10.1093/nar/gkn877. Epub 2008 Nov 7.
10
Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.T细胞抑制的细胞内在机制及其在癌症治疗中的应用。
Immunol Rev. 2008 Aug;224:141-65. doi: 10.1111/j.1600-065X.2008.00649.x.